Efficacy And Safety Of Carnitine Supplementation On NAFLD A Systematic Review And Meta Analysis

This research review examined whether L-carnitine supplements can help people with non-alcoholic fatty liver disease (NAFLD), a common condition where fat builds up in the liver without alcohol being the cause. NAFLD affects millions of people and is closely linked to metabolic issues like diabetes, obesity, and heart disease. The researchers wanted to understand if taking L-carnitine - a natural compound that helps the body turn fat into energy - could improve liver health and other metabolic markers.

The scientists analyzed eight high-quality studies involving people with NAFLD who took either L-carnitine supplements or placebo pills. They found that people taking L-carnitine showed improvements in several important areas: their liver enzymes (AST and ALT) decreased, indicating better liver function, and their cholesterol profile improved with higher HDL ("good" cholesterol) and lower triglycerides. These changes suggest that L-carnitine may help reduce liver inflammation and improve fat metabolism.

However, the researchers noted that the evidence quality was low to moderate, meaning more studies are needed to confirm these benefits. The studies varied in how long people took the supplements and what doses they used, making it difficult to determine the optimal treatment approach. Additionally, no serious side effects were reported, suggesting L-carnitine supplementation appears relatively safe.

For patients interested in metabolic health, this research suggests L-carnitine might be a useful supplement for supporting liver health, especially for those with fatty liver disease. However, it's important to work with a healthcare provider to determine if L-carnitine supplementation is appropriate for your individual situation and to monitor liver function over time.